Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about EDIT
Recent news which mentions EDIT
< Previous
1
2
3
4
5
6
7
8
9
Next >
Where Editas Medicine Stands With Analysts
September 17, 2024
Tickers
EDIT
Tags
EDIT
Analyst Ratings
Market News
From
Benzinga
Looking for Stock Bargains With Room to Run? Try This.
September 11, 2024
Tickers
AAPL
AMZN
BJRI
CBRL
Tags
AMZN
WBA
EDIT
From
Motley Fool
Boot Barn To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Thursday
August 08, 2024
Tickers
BMBL
BOOT
CENTA
CRL
Tags
DIN
Analyst Ratings
Market News
From
Benzinga
3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition
July 17, 2024
Tickers
CRSP
EDIT
NTLA
Tags
Market News
NTLA
Stocks to Buy
From
InvestorPlace
3 Profitable CRISPR Stocks Earning Analysts’ Praise
July 09, 2024
Tickers
CRSP
EDIT
NTLA
Tags
Stocks to Buy
NTLA
NASDAQ:CRSP,NASDAQ:NTLA,NASDAQ:EDIT
From
InvestorPlace
The 3 Best Gene Editing Stocks to Buy in July 2024
July 08, 2024
Tickers
CRSP
EDIT
GNOM
ILMN
Tags
EDIT
GNOM
Market News
From
InvestorPlace
Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich
June 26, 2024
Tickers
CRSP
EDIT
NLTA
Tags
NASDAQ:CRSP,NASDAQ:EDIT,NASDAQ:NLTA
CRSP
EDIT
From
InvestorPlace
3 Gene Editing Stocks That Could Make Your Grandchildren Rich
June 25, 2024
Tickers
CRSP
EDIT
NTLA
Tags
EDIT
NASDAQ:CRSP,NASDAQ:EDIT,NASDAQ:NTLA
CRSP
From
InvestorPlace
Unveiling 5 Analyst Insights On Editas Medicine
June 18, 2024
Tickers
EDIT
Tags
BZI/AAR
Benzinga
Analyst Ratings
From
Benzinga
The Analyst Verdict: Editas Medicine In The Eyes Of 4 Experts
May 30, 2024
Tickers
EDIT
Tags
EDIT
Market News
Analyst Ratings
From
Benzinga
Overlooked and Undervalued: 3 Stocks With Jaw-Dropping Upside Potential
May 30, 2024
Tickers
CNXC
EDIT
Z
Tags
CNXC
NASDAQ:Z,NASDAQ:EDIT,NASDAQ:CNXC
Z
From
InvestorPlace
1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?
May 09, 2024
Tickers
C
EDIT
Tags
Recent Press Releases
C
Market News
From
Motley Fool
EDIT Stock Earnings: Editas Medicine Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
Tickers
EDIT
Tags
Earnings Reports
Market News
NASDAQ:EDIT
From
InvestorPlace
1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right.
March 07, 2024
Tickers
EDIT
Tags
Recent Press Releases
Market News
EDIT
From
Motley Fool
1 Beaten-Down Stock With 55% Upside, According to Wall Street
March 04, 2024
Tickers
EDIT
Tags
Market News
EDIT
Recent Press Releases
From
Motley Fool
Why Editas Medicine Stock Soared as Much as 42% Higher This Week
March 02, 2024
Tickers
C
EDIT
VRTX
Tags
EDIT
Market News
C
From
Motley Fool
The Latest Analyst Ratings For Editas Medicine
February 29, 2024
Tickers
EDIT
Tags
Market News
Analyst Ratings
EDIT
From
Benzinga
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 28, 2024
Tickers
AAP
ACMR
ADIL
ADT
Tags
IMNN
Small Cap
IFBD
From
Benzinga
Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday
February 28, 2024
Tickers
AAP
ACMR
ADT
ADY
Tags
LTH
Penny Stocks
Benzinga
From
Benzinga
Earnings Outlook For Editas Medicine
February 27, 2024
Tickers
EDIT
Tags
Benzinga
BZI/EP
EDIT
From
Benzinga
2 Under-the-Radar Stocks With Incredible Upside Potential
January 28, 2024
Tickers
EDIT
RXRX
Tags
EDIT
RXRX
Market News
From
Motley Fool
Could Editas Medicine Become the Next CRISPR Therapeutics?
January 21, 2024
Tickers
CRSP
EDIT
Tags
Market News
EDIT
CRSP
From
Motley Fool
7 Mighty Healthcare Stocks Changing the Game of Medicine
January 17, 2024
Tickers
ASXC
EDIT
HOLX
ILMN
Tags
VERV
HOLX
EDIT
From
InvestorPlace
Down 88%, Could Editas Medicine Be a Good Investment Now?
January 15, 2024
Tickers
CRSP
EDIT
VRTX
Tags
Recent Press Releases
CRSP
VRTX
From
Motley Fool
3 Stocks to Buy in the Booming Field of Gene Editing
January 11, 2024
Tickers
BEAM
EDIT
LLY
VERV
Tags
VERV
NASDAQ:EDIT,NASDAQ:VRTX,NASDAQ:BEAM,NASDAQ:VERV,NYSE:LLY
EDIT
From
InvestorPlace
Better Gene-Editing Stock: Editas Medicine vs. Intellia Therapeutics
January 08, 2024
Tickers
EDIT
NTLA
Tags
Market News
NTLA
EDIT
From
Motley Fool
Editas Just Caught a Break Thanks to Vertex Pharmaceuticals
December 23, 2023
Tickers
EDIT
VRTX
Tags
VRTX
Recent Press Releases
Market News
From
Motley Fool
Vertex’s stock heads for all-time high as non-opioid painkiller shows promise
December 13, 2023
Tickers
EDIT
SPX
VRTX
VTRS
Tags
VTRS
VRTX
SPX
From
MarketWatch
The Latest Analyst Ratings for Editas Medicine
December 12, 2023
Tickers
EDIT
Tags
EDIT
Market News
Analyst Ratings
From
Benzinga
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
December 08, 2023
Tickers
BLUE
CRSP
EDIT
VRTX
Tags
VRTX
CRSP
BLUE
From
MarketWatch
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit